Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBay Pharmaceuticals (NBY) Divestments (2024)

Historic Divestments for NovaBay Pharmaceuticals (NBY) over the last 3 years, with Q1 2024 value amounting to $1.1 million.

  • NovaBay Pharmaceuticals' Divestments changed N/A to $1.1 million in Q1 2024 from the same period last year, while for Dec 2024 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2024, which is N/A changed from last year.
  • Per NovaBay Pharmaceuticals' latest filing, its Divestments stood at $1.1 million for Q1 2024.
  • In the past 5 years, NovaBay Pharmaceuticals' Divestments ranged from a high of $1.1 million in Q1 2024 and a low of $1.1 million during Q1 2024